Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

Summary

This is an investigator initiated trial to assess the efficacy and safety of a GCC-targeting CAR-T therapy (WD-01) in the metastatic colorectal cancer.

Timeline

Start

2025-05-18

Primary completion

2027-12-30

Completion

2029-12-30

Outcome

Outcome not reported

Stopped: “Because the implementation of the new regulation policy by the Chinese authority”

Drugs

Indications